TMO announced a cash dividend of 0.35 with an ex-date of Jun. 14, 2023
|Bid||518.00 x 1000|
|Ask||525.75 x 1800|
|Day's Range||518.69 - 526.92|
|52 Week Range||475.77 - 611.06|
|Beta (5Y Monthly)||0.79|
|PE Ratio (TTM)||33.91|
|Earnings Date||Jul 26, 2023 - Jul 31, 2023|
|Forward Dividend & Yield||1.40 (0.27%)|
|Ex-Dividend Date||Jun 14, 2023|
|1y Target Est||627.68|
Subscribe to Yahoo Finance Plus to view Fair Value for TMOLearn more
Thermo Fisher Scientific (TMO) closed at $520.14 in the latest trading session, marking a +0.15% move from the prior day.
Key Insights Thermo Fisher Scientific's estimated fair value is US$388 based on 2 Stage Free Cash Flow to Equity Thermo...
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Three years since the pandemic upended the economy, here are the Massachusetts public companies that made it through in the best — and worst — shape.
WALTHAM, Mass., May 24, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.35 per common share, payable on July 14, 2023, to shareholders of record as of June 15, 2023.
Thermo Fisher (TMO) latest expansion will enable it to better assist clients in accelerating their research, development and marketing of medications and vaccines in the Asia-Pacific region.
WALTHAM, Mass., May 24, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its 2023 Investor Day today and provided an in-depth review of the Company’s proven growth strategy and its industry-leading businesses: Life Science Solutions, Analytical Instruments, Specialty Diagnostics and Laboratory Products and Biopharma Services.
After the bear market of 2022, the markets have made a recovery in 2023, with both the S&P 500 and, in particular, the NASDAQ showing healthy year-to-date gains. Therefore, it might be a natural instinct for investors who have nursed heavy losses to be eyeing the exit gate now that the market is rebalancing and the initial investment is back to breaking even. However, legendary investor Ken Fisher says that kind of thinking is a big mistake. “As initial bull market rallies build, investors — raw
Thermo Fisher (TMO) announces the FDA clearance of its blood-based biomarkers used in the determination of risk assessment and clinical management of preeclampsia with severe features.
WALTHAM, Mass., May 22, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Bernstein 39th Annual Strategic Decisions Conference on Wednesday, May 31, 2023 at 11:00 a.m. (EDT).
There are many great stocks with proven and resilient businesses that investors should feel comfortable buying now at rather attractive levels and holding for the long haul. The two stocks we dive into today are Thermo Fisher Scientific Inc. (TMO) and Visa Inc. (V).
The FDA has reportedly approved Thermo Fisher Scientific Inc's (NYSE: TMO) blood test for preeclampsia, which causes pregnancy-related illness and death, to aid in the risk assessment of pregnant women within the next two weeks. It is the first and only blood-based biomarker immunoassay to receive breakthrough designation and clearance for the risk assessment and clinical management of preeclampsia. Preeclampsia is a serious blood pressure condition that develops during pregnancy. In addition to
The U.S. Food and Drug Administration (FDA) has cleared Thermo Fisher Scientific Inc's test, the first of its kind in the country, to detect women with risk of severe preeclampsia, the company said on Friday. Preeclampsia is a leading cause of mortality in pregnant women globally, where they could experience high blood pressure after 20 weeks of pregnancy and during the postpartum period. The condition happens in about 1 in 25 pregnancies in the United States, according to the U.S. Centers for Disease Control and Prevention.
WALTHAM, Mass., May 19, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Thermo Scientific B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR novel biomarkers, the first and only immunoassays to receive breakthrough designation and clearance for the risk assessment and clinical management of preeclampsia, a severe pregnancy complication.
Thermo Fisher’s blood test is the first cleared to predict life-threatening preeclampsia during pregnancy.
Thermo Fisher Scientific Inc. ( NYSE:TMO ) shareholders might be concerned after seeing the share price drop 11% in the...
Broadcom, Bank of America, Thermo Fisher Scientific, Chubb Limited and Aon are part of the Zacks top Analyst Blog.
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Bank of America (BAC) and Thermo Fisher Scientific (TMO).
WALTHAM, Mass., May 17, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today released its annual Corporate Social Responsibility (CSR) report. The report highlights the company’s commitment to society and stakeholders and provides insight into its CSR progress and environmental, social and governance (ESG) efforts.
In this article, we discuss billionaire Ken Fisher’s top 15 dividend stock picks. You can skip our detailed analysis of Fisher’s hedge fund and his investment philosophy, and go directly to read Billionaire Ken Fisher’s Top 5 Dividend Stock Picks. Ken Fisher’s Fisher Asset Management is one of the most prominent hedge funds in America. […]
In this piece, we will take a look at Morgan Stanley’s top 15 stock picks for 2023. For more Morgan Stanley stocks, head on over to Morgan Stanley’s Top 5 Stock Picks For 2023. If there’s one thing that can be said for sure about 2022, it’s that the year turned out to be a […]
Thermo Fisher's (TMO) latest collaboration with Pfizer is set to enhance localized access to NGS-based testing capabilities for breast and lung cancer across international markets.
WALTHAM, Mass., May 09, 2023--Pfizer and Thermo Fisher Scientific Inc. (NYSE: TMO) today announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable. Access to local NGS testing can help to provide faster analysis of associated ge
In this article, we discuss 10 best scientific instruments stocks to buy. If you want to see more stocks in this selection, check out 5 Best Scientific Instruments Stocks To Buy. Scientific instruments are tools used to measure, record, and indicate physical quantities, aiding in scientific research and new product development. These instruments are designed […]